Ependion AB (LON:0GT8)

Theseus Pharmaceuticals Revenue

Ependion AB had revenue of 560.76M SEK in the quarter ending June 30, 2025, a decrease of -4.69%. This brings the company's revenue in the last twelve months to 2.18B, down -9.14% year-over-year. In the year 2024, Ependion AB had annual revenue of 2.26B, down -8.60%.

• Revenue (ttm): 2.18B SEK
• Revenue Growth: -9.14%
• P/S Ratio: 1.75
• Revenue / Employee: 2.53M SEK
• Employees: 861
• Market Cap: 292.83M USD

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.26B	-212.52M	-8.60%
Dec 31, 2023	2.47B	342.26M	16.08%
Dec 31, 2022	2.13B	509.59M	31.48%
Dec 31, 2021	1.62B	181.05M	12.59%
Dec 31, 2020	1.44B	-120.95M	-7.76%